| Mismatch negativity in chronic schizophrenia and first-episode schizophrenia DF Salisbury, ME Shenton, CB Griggs, A Bonner-Jackson, RW McCarley Archives of general psychiatry 59 (8), 686-694, 2002 | 348 | 2002 |
| The influence of encoding strategy on episodic memory and cortical activity in schizophrenia A Bonner-Jackson, K Haut, JG Csernansky, DM Barch Biological psychiatry 58 (1), 47-55, 2005 | 133 | 2005 |
| Verbal and non-verbal memory and hippocampal volumes in a memory clinic population A Bonner-Jackson, S Mahmoud, J Miller, SJ Banks Alzheimer's research & therapy 7, 1-10, 2015 | 131 | 2015 |
| Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophrenia and bipolar disorder C Rosen, LS Grossman, M Harrow, A Bonner-Jackson, R Faull Comprehensive Psychiatry 52 (2), 126-131, 2011 | 108 | 2011 |
| Retinal nerve fiber layer thinning in Alzheimer’s disease: a case–control study in comparison to normal aging, Parkinson’s disease, and non-Alzheimer’s dementia JA Pillai, R Bermel, A Bonner-Jackson, A Rae-Grant, H Fernandez, ... American Journal of Alzheimer's Disease & Other Dementias® 31 (5), 430-436, 2016 | 102 | 2016 |
| Neurocognition in schizophrenia: a 20-year multi–follow-up of the course of processing speed and stored knowledge A Bonner-Jackson, LS Grossman, M Harrow, C Rosen Comprehensive psychiatry 51 (5), 471-479, 2010 | 101 | 2010 |
| Cognitive reserve and brain reserve in prodromal Huntington's disease A Bonner-Jackson, JD Long, H Westervelt, G Tremont, E Aylward, ... Journal of the International Neuropsychological Society 19 (7), 739-750, 2013 | 80 | 2013 |
| Neurocognitive profiles in patients with persisting cognitive symptoms associated with COVID-19 K Krishnan, AK Miller, K Reiter, A Bonner-Jackson Archives of Clinical Neuropsychology 37 (4), 729-737, 2022 | 67 | 2022 |
| Outer retinal assessment using spectral-domain optical coherence tomography in patients with Alzheimer's and Parkinson's disease A Uchida, JA Pillai, R Bermel, A Bonner-Jackson, A Rae-Grant, ... Investigative ophthalmology & visual science 59 (7), 2768-2777, 2018 | 58 | 2018 |
| Episodic memory in schizophrenia: the influence of strategy use on behavior and brain activation A Bonner-Jackson, N Yodkovik, JG Csernansky, DM Barch Psychiatry Research: Neuroimaging 164 (1), 1-15, 2008 | 58 | 2008 |
| Genetic risk for Alzheimer's disease alters the five-year trajectory of semantic memory activation in cognitively intact elders SM Rao, A Bonner-Jackson, KA Nielson, M Seidenberg, JC Smith, ... Neuroimage 111, 136-146, 2015 | 51 | 2015 |
| Levels-of-processing effects in first-degree relatives of individuals with schizophrenia A Bonner-Jackson, JG Csernansky, DM Barch Biological psychiatry 61 (10), 1141-1147, 2007 | 43 | 2007 |
| Apolipoprotein E ɛ2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease A Bonner-Jackson, O Okonkwo, G Tremont, ... The American journal of geriatric psychiatry 20 (7), 584-593, 2012 | 37 | 2012 |
| Cross‐sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease DL Harrington, JD Long, S Durgerian, L Mourany, K Koenig, ... Movement Disorders 31 (11), 1664-1675, 2016 | 33 | 2016 |
| Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease JA Pillai, A Bonner-Jackson, E Walker, L Mourany, JL Cummings Dementia and geriatric cognitive disorders 38 (3-4), 224-233, 2014 | 32 | 2014 |
| Strategic manipulations for associative memory and the role of verbal processing abilities in schizophrenia A Bonner-Jackson, DM Barch Journal of the International Neuropsychological Society 17 (5), 796-806, 2011 | 31 | 2011 |
| Highly elevated cerebrospinal fluid total tau level reflects higher likelihood of non-amnestic subtype of Alzheimer’s disease JA Pillai, A Bonner-Jackson, LM Bekris, J Safar, J Bena, JB Leverenz Journal of Alzheimer's Disease 70 (4), 1051-1058, 2019 | 27 | 2019 |
| Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease JA Pillai, J Bena, G Bebek, LM Bekris, A Bonner‐Jackson, L Kou, A Pai, ... Annals of Clinical and Translational Neurology 7 (7), 1225-1239, 2020 | 21 | 2020 |
| Impact of Alzheimer's disease, Lewy body and vascular co-pathologies on clinical transition to dementia in a national autopsy cohort JA Pillai, RS Butler, A Bonner-Jackson, JB Leverenz Dementia and geriatric cognitive disorders 42 (1-2), 106-116, 2016 | 20 | 2016 |
| Review of information and communication technology devices for monitoring functional and cognitive decline in Alzheimer's disease clinical trials JA Pillai, A Bonner-Jackson Journal of Healthcare Engineering 6, 71-84, 2015 | 11 | 2015 |
